ethyl α-methyl-γ-piperidinobutyrate | 49637-22-1

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: ethyl α-methyl-γ-piperidinobutyrate
• 英文别名: ethyl-2-methyl-4-piperidinobutyrate；2-methyl-4-piperidin-1-yl-butyric acid ethyl ester；Ethyl 2-methyl-4-piperidinobutyrate；ethyl 2-methyl-4-piperidin-1-ylbutanoate
• CAS: 49637-22-1
• 化学式: C₁₂H₂₃NO₂
• 分子量: 213.32
• InChiKey: BATCSNGUUOOSBY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  15
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.92
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  ethyl α-methyl-γ-piperidinobutyrate 在 盐酸 作用下， 以 乙醚 、 水 为溶剂， 生成 α-methyl-γ-piperidinobutyric acid hydrochloride
  参考文献：
  名称：

  Novel heterocyclic esters of benzopyranopyridines

  摘要：

  这是一个关于苯并吡啶酮的新型杂环酯的化学式，其表示为## STR1 ##其中R.sub.1为氢，低烷基，低酰基，环烷基-低烷基，环烷基-低酰基，低烯基，低炔基，卤代-低烯基，苯基-低烷基，苯基-低烯基或苯基-低炔基；R.sub.2为低烷基；R.sub.3为具有一到二十个碳原子的烷基或环烷基-低烷基；Y为具有一到八个碳原子的直链或支链烷基；R.sub.4为## STR2 ##其中a为1到4的整数，b为1到4的整数，X为CH.sub.2，O，S或N--R.sub.5，其中R.sub.5为氢或低烷基，但当X为O，S或N--R.sub.5时，a和b必须各为2，R.sub.6为氢或连接到环中碳原子的低烷基基团；以及它们的酸加合物盐。

  公开号：

  US04042694A1
• 作为产物：
  描述：

  4-溴-2-甲基丁酸乙酯 、 哌啶 以 苯 为溶剂， 反应 20.0h， 生成 ethyl α-methyl-γ-piperidinobutyrate
  参考文献：
  名称：

  Anesthesia methods using benzopyrans and esters thereof as

  摘要：

  改进的麻醉方法包括使用式I的苯并吡喃预处理待麻醉的患者，其中在C环中，X为NR.sub.1，S，CH.sub.2或##STR2##，R.sub.1为氢，低烷基，低烯基，低炔基，低酰基，环烷基低烷基，环烷基低酰基，环烷基，卤代低烷基，卤代低烯基，苯基低烷基，苯基低烯基或苯基低烷基基；m为0至3的整数，n为0至3的整数，n + m = 2或3；或C环为喹啉环##STR3##，R.sub.2为低烷基；R.sub.3为氢或##STR4##，其中Y为直链或支链烷基链，具有1至8个碳原子，a为1至4的整数，b为1至4的整数，Z为CH.sub.2，O，S或NR.sub.6，其中R.sub.6为氢或低烷基，限制条件为当Z为O，S或NR.sub.5时，a和b的和为3或4，R.sub.5为氢或低烷基；R.sub.4为C.sub.1-C.sub.20直链或支链烷基，环烷基，或##STR5##，其中Y为具有1至10个碳原子的直链或支链烷基链，每个R.sub.7，R.sub.8和R.sub.9是相同或不同的羟基，卤素，三氟甲基或低烷基成员的群；及其药学上可接受的盐，限制条件为当X为##STR6##时，m = 2且n = 2时，R.sub.3不能为氢。

  公开号：

  US04025630A1

文献信息

• [EN] ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR INHIBITORS<br/>[FR] INHIBITEURS DE RÉCEPTEURS NICOTINIQUES ALPHA-7 DE L'ACÉTYLCHOLINE
  申请人：WYETH CORP

  公开号：WO2010009290A1

  公开（公告）日：2010-01-21

  The present invention provides compounds and compositions, methods of making them, and methods of using them to modulate α7 nicotinic acetylcholine receptors and/or to treat any of a variety of disorders, diseases, and conditions. Provided compounds can affect, among other things, neurological, psychiatric and/or inflammatory systems.

  本发明提供了化合物和组合物，制备它们的方法，以及利用它们调节α7烟碱乙酰胆碱受体和/或治疗各种疾病、疾病和症状的方法。所提供的化合物可以影响神经系统、精神病学和/或炎症系统等方面。
• Esters of thienobenzopyrans and thiopyranobenzopyrans
  申请人：Sharps Associates

  公开号：US03960871A1

  公开（公告）日：1976-06-01

  Novel thienobenzopyran and thiopyranobenzopyran esters represented by the formula ##SPC1## Wherein n is 0 to 3 and m is 0 to 3 and m + n = 2 or 3, R.sub.1 is lower alkyl, R.sub.2 is alkyl or cycloalkyl-lower alkyl, R.sub.4 is hydrogen or lower alkyl, R.sub.5 is hydrogen or lower alkyl, and R.sub.3 is ##EQU1## wherein Y is a straight or branched chain C.sub.1 to C.sub.8 alkylene, R.sub.6 is hydrogen or a lower alkyl, a is an integer from 1 to 4, b is an integer from 1 to 4, X is CH.sub.2, O, S or NR.sub.7 wherein R.sub.7 is hydrogen or lower alkyl, with the limitation that when X is O, S or NR.sub.7, a and b each must be 2; and the acid addition salts thereof.

  新颖的噻吲并苯并吡喃酯和噻吲并苯并吡喃酯的化学式为##SPC1## 其中n为0至3，m为0至3，且m + n = 2或3，R.sub.1为较低的烷基，R.sub.2为烷基或环烷基-较低的烷基，R.sub.4为氢或较低的烷基，R.sub.5为氢或较低的烷基，R.sub.3为##EQU1## 其中Y为直链或支链C.sub.1至C.sub.8的烷基，R.sub.6为氢或较低的烷基，a为1至4的整数，b为1至4的整数，X为CH.sub.2、O、S或NR.sub.7，其中R.sub.7为氢或较低的烷基，限制条件是当X为O、S或NR.sub.7时，a和b必须分别为2；及其酸盐。
• Heterocyclic esters of alkylphenyl benzopyranopyridines
  申请人：Abbott Laboratories

  公开号：US04081449A1

  公开（公告）日：1978-03-28

  Heterocyclic esters of alkylphenyl benzopyranopyridines represented by the formula ##STR1## wherein R.sub.1 is hydrogen, loweralkyl, loweralkanoyl, cycloalkylloweralkyl, cycloalkylloweralkanoyl, loweralkenyl, loweralkynyl, haloloweralkenyl, phenylloweralkyl, phenylloweralkenyl or phenylloweralkynyl; R.sub.2 is loweralkyl; R.sub.3 is ##STR2## WHEREIN X is a straight or branched chain alkylene group having from one to eight carbon atoms, a is an integer from 1 to 4, b is an integer from 1 to 4 and Z is CH.sub.2, O, S or NR.sub.7, with R.sub.7 being hydrogen or loweralkyl, with the limitation that when X is O, S or NR.sub.7, the sum of a and b is 3 or 4; and R.sub.8 is hydrogen or loweralkyl; Y is a straight or branched chain alkylene group having from one to ten carbon atoms; and each R.sub.4 and R.sub.5 and R.sub.6 are the same or different members of the group consisting of hydrogen, halo, trifluoromethyl or loweralkyl; and the pharmaceutically acceptable acid addition salts thereof.

  以式##STR1##所代表的烷基苯基苯并吡啶酮的杂环酯，其中R.sub.1是氢、低烷基、低烷酰、环烷基低烷基、环烷基低烷酰、低烯基、低炔基、卤代低烯基、苯基低烷基、苯基低烯基或苯基低炔基；R.sub.2是低烷基；R.sub.3是##STR2##其中X是具有1至8个碳原子的直链或支链烷基基团，a是1到4的整数，b是1到4的整数，Z是CH.sub.2、O、S或NR.sub.7，其中R.sub.7是氢或低烷基，限制条件是当X为O、S或NR.sub.7时，a和b的总和为3或4；R.sub.8是氢或低烷基；Y是具有1到10个碳原子的直链或支链烷基基团；每个R.sub.4和R.sub.5和R.sub.6是相同或不同的成员，包括氢、卤素、三氟甲基或低烷基；以及其药用可接受的酸盐。
• Heterocyclic esters of benzopyranopyridines
  申请人：Sharps Associates

  公开号：US03991194A1

  公开（公告）日：1976-11-09

  Novel heterocyclic esters of benzopyranopyridines represented by the formula ##SPC1## Wherein R.sub.1 is hydrogen, lower alkyl, lower alkanoyl, cycloalkyl-lower alkyl, cycloalkyl-lower alkanoyl, lower alkenyl, lower alkynyl, halo-loweralkenyl, phenyl-lower alkyl, phenyl-lower alkenyl or phenyl-lower alkynyl; R.sub.2 is lower alkyl; R.sub.3 is an alkyl having one to twenty carbon atoms or a cycloalkyl-lower alkyl, Y is a straight or branched chain alkylene having one to eight carbon atoms, and R.sub.4 is a group of the formula ##EQU1## a is an integer from 1 to 4, b is an integer from 1 to 4 and X is CH.sub.2, O, S or N--R.sub.5 with R.sub.5 being hydrogen or lower alkyl, with the limitation that when X is O, S or N--R.sub.5, a and b each must be 2 and R.sub.6 is hydrogen or a lower alkyl group bonded to a carbon in the ring; and the acid addition salts thereof.

  该文献描述的是苯并吡啶酮的新异环酯类化合物，其化学式为##SPC1##其中，R.sub.1为氢、低碳基、低脂肪酰基、环烷基-低碳基、环烷基-低脂肪酰基、低烯基、低炔基、卤代-低烯基、苯基-低碳基、苯基-低烯基或苯基-低炔基；R.sub.2为低碳基；R.sub.3为具有1-20个碳原子的烷基或环烷基-低碳基；Y为直链或支链烷基，具有1-8个碳原子；R.sub.4为式子##EQU1##其中，a为1-4的整数，b为1-4的整数，X为CH.sub.2、O、S或N--R.sub.5，其中R.sub.5为氢或低碳基；但当X为O、S或N--R.sub.5时，a和b必须各为2，R.sub.6为氢或与环中碳原子成键的低碳基；以及它们的酸加成盐。
• Morpholine containing esters of thienobenzopyrans and
  申请人：Sharps Associates

  公开号：US03972880A1

  公开（公告）日：1976-08-03

  Novel thienobenzopyran and thiopyranobenzopyran esters represented by the formula ##SPC1## Wherein n is 0 to 3 and m is 0 to 3 and m + n = 2 or 3, R.sub.1 is lower alkyl, R.sub.2 is alkyl or cycloalkyl-lower alkyl, R.sub.4 is hydrogen or lower alkyl, R.sub.5 is hydrogen or lower alkyl, and R.sub.3 is ##EQU1## wherein Y is a straight or branched chain C.sub.1 to C.sub.8 alkylene, R.sub.6 is hydrogen or a lower alkyl, a is an integer from 1 to 4, b is an integer from 1 to 4, X is CH.sub.2, O, S or NR.sub.7 wherein R.sub.7 is hydrogen or lower alkyl, with the limitation that when X is O, S or NR.sub.7, a and b each must be 2; and the acid addition salts thereof.

  本发明涉及一种由以下公式表示的新型噻吩并苯并噻吩酯：##SPC1## 其中n为0至3，m为0至3且m + n = 2或3，R.sub.1为低碳基，R.sub.2为烷基或环烷基-低碳基，R.sub.4为氢或低碳基，R.sub.5为氢或低碳基，且R.sub.3为##EQU1## 其中Y为直链或支链的C.sub.1至C.sub.8烷基，R.sub.6为氢或低碳基，a为1至4的整数，b为1至4的整数，X为CH.sub.2，O，S或NR.sub.7，其中R.sub.7为氢或低碳基，但当X为O，S或NR.sub.7时，a和b必须各为2；以及其酸加成盐。